Datopotamab deruxtecan
Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2) -targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.
Product Specifications
CAS Number
2238831-60-0
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
Topoisomerase | Antibody-Drug Conjugates (ADCs)
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog